Firma T-knife, Autor bei PR-Web

T-knife Therapeutics Announces $110 Million Series B Financing to Advance Pipeline of T-cell Receptor Therapies

Posted on 2. August 20212. August 2021 by Firma T-knife Posted in Research / Development Tagged cancer, cd8, cell, cells, clinical, ctas, hla, hutcr, mage, mice, patients, tcr, tcrs, versant, with

T-knife Therapeutics, Inc., a next-generation T-cell receptor company developing a pipeline of innovative therapeutics for solid tumor patients, today announced the successful completion of a $110 million Series B financing. The financing was led by Fidelity Management & Research Company, […]

T-knife Therapeutics Announces the Appointment of Megan Baierlein as Chief Operating Officer

Posted on 12. July 202113. July 2021 by Firma T-knife Posted in Research / Development Tagged cancer, cell, clinical, company, mage, patients, pharmaceutical, platform, prior, soloway, tcr, therapeutics, treatment, tumor, with

T-knife Therapeutics, Inc., a next-generation T-cell receptor company developing a pipeline of innovative therapeutics for solid tumor patients, today announced the appointment of Megan Baierlein as chief operating officer. “We are excited to welcome Megan to our executive leadership team,” […]